Ainos, Inc. (AIMDW)

US — Healthcare Sector
Peers:

Automate Your Wheel Strategy on AIMDW

With Tiblio's Option Bot, you can configure your own wheel strategy including AIMDW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol AIMDW
  • Rev/Share 0.0067
  • Book/Share 0.8272
  • PB 0.7632
  • Debt/Equity 0.9145
  • CurrentRatio 2.0027
  • ROIC -0.5376

 

  • MktCap 13232174.0
  • FreeCF/Share -0.3523
  • PFCF -2.3677
  • PE -0.6751
  • Debt/Assets 0.4554
  • DivYield 0
  • ROE -0.8807

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Ainos, Inc. (AIMDW)

  • IPO Date
  • Website https://www.ainos.com
  • Industry Biotechnology
  • CEO Mr. Chun-Hsien Tsai
  • Employees 44
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.